Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy

PURPOSE: To evaluate costs of panretinal photocoagulation (PRP) vs. intravitreal ranibizumab (IVR) for proliferative diabetic retinopathy (PDR). DESIGN: A Markov-style model of cost-effectiveness and cost utility. PARTICIPANTS: There were no participants. METHODS: Based on results from Diabetic Reti...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ophthalmology
Main Authors: Lin, James, Chang, Jonathan S, Smiddy, William E
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4995116/
https://ncbi.nlm.nih.gov/pubmed/27425822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.05.037
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki